Running for Your Life: Share This

What a downhill trajectory …

Once upon a time, business had a simple obsession with market share. The idea being that your product, or service, or whatever it is you're selling, should aspire to have a high (and higher!) percentage of the market share of business spending.

Almost twenty years ago, I edited a Wall Street Journal story on what was a new phenomenon in my books: stomach share.

In this instance, Coke marketers were investigating research algorithms to track a consumer’s stomach share, as in how much Coke was in an individual stomach, compared to other drinks and food, and what time of day too. Coke float for breakfast?

Okay, now under Trump’s deregulation regime, in which the FDA stands to be even less vigilant during Obama’s rule, expect vomit share to have its day.

Conjecture: Can we trust drug companies NOT to develop appetite suppression side effects to common medication so that, well, if not outright nausea-producing, the drug bits of their multibillion-dollar products show up in a greater and greater share of a consumer vomit. (Appetite suppression being critical to keep folks from, well, consuming other things beyond their drug products.)

Point of fact: Plenty of healthy food nutrients will treat most common ailments, but it’s not as though US health authorities go to any lengths to draw that to our attention.

Why would you think they would start to being concerned about consumers' total health and well-being now?

Truth is the “science” of drugs in America promote the drugmakers. As is “elite science” when it comes to debunking spiritualism, the topic of my next blog post, when Scientific American magazine set out to find definable proof that there is such a thing as ghosts …


Next: Running for Your Life: Through a Glass, Darkly

0 comments: